UY31420A1 - Arilindenopirimidinas y su uso como antagonistas del receptor a2a de adenosina - Google Patents
Arilindenopirimidinas y su uso como antagonistas del receptor a2a de adenosinaInfo
- Publication number
- UY31420A1 UY31420A1 UY31420A UY31420A UY31420A1 UY 31420 A1 UY31420 A1 UY 31420A1 UY 31420 A UY31420 A UY 31420A UY 31420 A UY31420 A UY 31420A UY 31420 A1 UY31420 A1 UY 31420A1
- Authority
- UY
- Uruguay
- Prior art keywords
- arylindenopirimidins
- adenosine
- antagonists
- receiver
- arylindenopyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiere a una nueva arilindenopirimidina, A, y a sus usos terapéuticos y profilácticos. Los trastornos tratados o evitados incluyen la enfermedad de Parkinson.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98224707P | 2007-10-24 | 2007-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31420A1 true UY31420A1 (es) | 2009-04-30 |
Family
ID=40091927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31420A UY31420A1 (es) | 2007-10-24 | 2008-10-24 | Arilindenopirimidinas y su uso como antagonistas del receptor a2a de adenosina |
Country Status (12)
Country | Link |
---|---|
US (1) | US8017614B2 (es) |
EP (1) | EP2217575A1 (es) |
JP (1) | JP2011500819A (es) |
CN (1) | CN101835759A (es) |
AR (1) | AR069009A1 (es) |
AU (1) | AU2008317034A1 (es) |
CL (1) | CL2008003131A1 (es) |
PA (1) | PA8801501A1 (es) |
PE (1) | PE20091344A1 (es) |
TW (1) | TW200934493A (es) |
UY (1) | UY31420A1 (es) |
WO (1) | WO2009055308A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110105540A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | 2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST |
WO2012031383A1 (zh) * | 2010-09-06 | 2012-03-15 | 中国科学院广州生物医药与健康研究院 | 酰胺类化合物 |
WO2013156614A1 (en) | 2012-04-20 | 2013-10-24 | Ucb Pharma S.A. | Methods for treating parkinson's disease |
CA3126735A1 (en) | 2019-01-11 | 2020-07-16 | Omeros Corporation | Methods and compositions for treating cancer |
WO2023201267A1 (en) | 2022-04-13 | 2023-10-19 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040127510A1 (en) | 2002-04-16 | 2004-07-01 | Heintzelman Geoffrey R. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
WO2005042500A1 (en) | 2003-10-03 | 2005-05-12 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
-
2008
- 2008-10-17 JP JP2010531141A patent/JP2011500819A/ja not_active Withdrawn
- 2008-10-17 AU AU2008317034A patent/AU2008317034A1/en not_active Abandoned
- 2008-10-17 CN CN200880112882A patent/CN101835759A/zh active Pending
- 2008-10-17 US US12/253,358 patent/US8017614B2/en not_active Expired - Fee Related
- 2008-10-17 WO PCT/US2008/080256 patent/WO2009055308A1/en active Application Filing
- 2008-10-17 EP EP08841238A patent/EP2217575A1/en not_active Withdrawn
- 2008-10-23 AR ARP080104625A patent/AR069009A1/es not_active Application Discontinuation
- 2008-10-23 PA PA20088801501A patent/PA8801501A1/es unknown
- 2008-10-23 PE PE2008001819A patent/PE20091344A1/es not_active Application Discontinuation
- 2008-10-23 CL CL2008003131A patent/CL2008003131A1/es unknown
- 2008-10-23 TW TW097140560A patent/TW200934493A/zh unknown
- 2008-10-24 UY UY31420A patent/UY31420A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008317034A1 (en) | 2009-04-30 |
CN101835759A (zh) | 2010-09-15 |
JP2011500819A (ja) | 2011-01-06 |
EP2217575A1 (en) | 2010-08-18 |
TW200934493A (en) | 2009-08-16 |
PE20091344A1 (es) | 2009-09-24 |
WO2009055308A1 (en) | 2009-04-30 |
CL2008003131A1 (es) | 2010-02-19 |
US8017614B2 (en) | 2011-09-13 |
PA8801501A1 (es) | 2009-05-15 |
AR069009A1 (es) | 2009-12-23 |
US20090111827A1 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28766A1 (es) | Compuestos heteropolicíclicos adicionales y su uso como antagonistas del receptor de glutamato metabotrópico | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
PA8548901A1 (es) | Ligandos del receptor 5-ht y sus usos | |
GT201300164A (es) | Derivados de biciclo (3.2.1.) octilamida y sus usos | |
CO6470876A2 (es) | 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octano- o heptano-nitrilo como inhibidores de jak. | |
ECSP11011019A (es) | Antagonistas del receptor de orexina de isonicotinamida | |
BRPI0614397A2 (pt) | compostos de pirimidina como moduladores de receptor de serotonina | |
UY32583A (es) | Composiciones y métodos para aumentar el crecimiento muscular | |
NO20080278L (no) | Prodrugs av A2B-adenosinreseptorantagonister | |
HN2008001530A (es) | Compuestos de amino pirimidina 2,6- sustituidos -4-monosustituidos como antagonistas del receptor de prostaglandina d2 | |
CL2008002864A1 (es) | Compuestos derivados de 2-amino-quinolina, antagonistas del receptor de serotonina 5-ht 5a; procedimiento de preparacion;composicion farmaceutica; y uso de los compuestos en la prevencion o el tratamiento de depresion,trastornos de ansiedad,esquizofrenia,trastornos de panico,trastornos de memoria,demencia,entre otros. | |
GT201000179A (es) | "antagonistas del receptor mineralcorticoide y metodos de uso" | |
UY31420A1 (es) | Arilindenopirimidinas y su uso como antagonistas del receptor a2a de adenosina | |
CO6321169A2 (es) | Metilenaminas de tieno[2,3-d] pirimidina y su uso como antagonistas de receptores de adenosina a2a | |
HN2006007774A (es) | Imidazoles sustituidos con heterociclilamida | |
UY31717A1 (es) | (pirazolilcarbonil) imidazolidinonas sustituidas y su uso | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso | |
CO6290689A2 (es) | Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica | |
ECSP12011840A (es) | Arilindenopirimidinas sustituidas con heteroarilo y su uso como antagonistas del receptor de adenosina a2a altamente selectivos | |
UY31421A1 (es) | Arilindenopirimidinas y su uso como adenosina a2a | |
ECSP12011842A (es) | ARILINDENOPIRIMIDINAS SUSTITUIDAS CON ALQUILO Y SU USO COMO ANTAGONISTAS DEL RECEPTOR DE ADENOSINA A2a ALTAMENTE SELECTIVOS | |
PA8567701A1 (es) | Agonistas del receptor b3-adrenergico | |
CL2008001007A1 (es) | Compuestos derivados de furo[2,3-b] piridina, moduladores del receptor canabinoide-1; y su uso para tratar psicosis, deficit de memoria, trastornos cognitivos, entre otras enfermedades. | |
ECSP12011844A (es) | 2-amino-9-[4-(4-metoxi-fenoxi)-piperidin-1-il]-4-fenil-indeno[1,2-d]pirimidin-5-ona y su uso como un antagonista del receptor de adenosina a2a altamente selectivo | |
SV2009002893A (es) | Procedimientos novedosos para la preparacion de derivados de piperacinil y diazapanil benzamida ref. prd2560 |